Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis

Pathology Research and Practice

Volumn 197, Issue 9, 2001, Pages 627-633

  Arihiro, Koji ^a,b   Inai, Kouki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Bone and soft tissue tumors; CD82; KAI1; Osteosarcoma

Indexed keywords

CD82 ANTIGEN;

ARTICLE; BENIGN TUMOR; BONE TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; OSTEOSARCOMA; OSTEOSARCOMA CELL; SOFT TISSUE TUMOR;

EID: 0034827961     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00137     Document Type: Article

References (42)

1. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer
2. Adhesion molecules in high-grade soft tissue sarcomas: Correlation to clinical outcome
3. Characterization of integrin-tetraspanin adhesion complexes: Role of tetraspanins in integrin signaling
4. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: A biphasic relationship with tumour grade
5. Non-isotopic in situ detection of mRNA for interleukin-4 in archival human tissue
6. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2
7. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
8. Genomic organization of the human KAI1 metastasis-suppressor gene
9. Reduced KAIl expression in pancreatic cancer is associated with lymph node and distant metastases
10. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: Altered glycosylation of C33 antigen in HTLV-1-positive T cells
11. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues
12. Integrin expression and function on human osteoblast-like cells
13. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma
14. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
15. Association of TM4SF proteins with integrins: Relevance to cancer
16. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: An immunohistochemical analysis
17. Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer
18. Use of avidin-biotin-complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures
19. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients
20. MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues
21. Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer
22. Signaling through the tetraspanin CD82 triggers its association with the cytoskeleton leading to sustained morphological changes and T cell activation
23. Loss of KAI1 expression in the progression of colorectal cancer
24. The tetraspanin superfamily: Molecular facilitators
25. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53
26. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases
27. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation
28. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein
29. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins
30. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer
31. KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases
32. Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma
33. Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells
34. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene
35. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma
36. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer
37. Integrin α2 β1 in tumorigenic human osteosarcoma cell lines regulates cell adhesion, migration, and invasion by interaction with type I collagen
38. Expression of KAI1 in paraffin-embedded normal, hyperplastic and neoplastic prostate and prostate carcinoma cell lines
39. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines
40. KAI1, a putative marker for metastatic potential in human breast cancer
41. Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas
42. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers